{
    "clinical_study": {
        "@rank": "159815", 
        "arm_group": {
            "arm_group_label": "prospective cohort study", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "Intraluminally shed viable tumor cells might contribute to local recurrence in cancer of the\n      esophagus and the cardia. The aim of the the study was to establish a method of mechanical\n      lavage of the remaining part of the esophagus and, hence, to reduce the intraluminal cancer\n      cells before doing the esophageal anastomosis."
        }, 
        "brief_title": "Esophageal Stump Washout", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Esophageal Cancer", 
            "Cancer of the Gastro-esophageal Junction"
        ], 
        "condition_browse": {
            "mesh_term": "Esophageal Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "See study protocol!"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histologically confirmed cancer of gastro-esophageal junction with indication for\n             surgery\n\n        Exclusion Criteria:\n\n          -  missing informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01980394", 
            "org_study_id": "Liestal-2012-OES"
        }, 
        "intervention": {
            "arm_group_label": "prospective cohort study", 
            "description": "a washout of the closed esophageal stump with Ringer-solution (10 times 30ml) is performed by means of a transorally inserted 24F-Foley catheter. The first, fifth and tenth portion of the lavage fluid are collected and sent to cytological examination", 
            "intervention_name": "Esophageal Stump Washout", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "esophagus", 
            "gastro-esophegeal junction", 
            "cancer", 
            "tumor seeding", 
            "free viable tumor cells", 
            "surgery", 
            "intraluminal tumor cells", 
            "stump washout"
        ], 
        "lastchanged_date": "November 4, 2013", 
        "location": {
            "contact": {
                "email": "christoph.maurer@ksli.ch", 
                "last_name": "Christoph A Maurer, MD", 
                "phone": "+41 61 925 21 50"
            }, 
            "facility": {
                "address": {
                    "city": "Liestal", 
                    "country": "Switzerland", 
                    "state": "Basel-Land", 
                    "zip": "4410"
                }, 
                "name": "Kantonsspital Baselland, Liestal"
            }, 
            "investigator": {
                "last_name": "Diana R Mattiello, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Esophageal Stump Washout Reduces Free Intraluminal Tumor Cells During Resection of Carcinomas of the Esophagus and Cardia", 
        "overall_official": {
            "affiliation": "Hospital of Liestal, Liestal, Switzerland", 
            "last_name": "Christoph A. Maurer, Professor, Chairman of Surgery", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Federal Office of Public Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Presence of intraluminal tumor cells in the remaining oesophageal stump", 
            "safety_issue": "Yes", 
            "time_frame": "during the operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01980394"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Kantonsspital Liestal", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Bern", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Kantonsspital Liestal", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2004", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}